# A Multicenter, Active and Placebo-controlled Study of Enteric Coated Sevelamer in Patients With Mild to Moderate Hypercholesteremia

> **NCT00690937** · PHASE2 · COMPLETED · sponsor: **Genzyme, a Sanofi Company** · enrollment: 120 (actual)

## Conditions studied

- Hypercholesterolemia

## Interventions

- **DRUG:** Enteric coated sevelamer
- **DRUG:** Enteric coated sevelamer
- **DRUG:** Colesevelam Cholestagel
- **DRUG:** Placebo
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00690937
- **Lead sponsor:** Genzyme, a Sanofi Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-02
- **Primary completion:** 2008-12
- **Final completion:** 2008-12
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2014-03-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00690937

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00690937, "A Multicenter, Active and Placebo-controlled Study of Enteric Coated Sevelamer in Patients With Mild to Moderate Hypercholesteremia". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00690937. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*